All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 250 | older 250) (20 | 50 | 100 | 250 | 500)- 01:03, 2 May 2024 Jwarner talk contribs created page Category:Guideline pages (Created page with "Category:General reference pages")
- 21:54, 28 April 2024 Jwarner talk contribs created page Tovorafenib (Ojemda) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovorafenib NCI Drug Dictionary]: An orally available inhibitor of wild-type...")
- 23:06, 22 April 2024 Jwarner talk contribs created page Nogapendekin alfa inbakicept (Anktiva) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa NCI Drug Dictionary]: A fusion protein complex composed of...")
- 10:38, 14 April 2024 Jwarner talk contribs moved page Iptacopan (LNP-023) to Iptacopan (Fabhalta) (FDA approval)
- 18:05, 12 April 2024 Jwarner talk contribs created page CARv3-TEAM-E T-cells (Created page with "==Mechanism of action== anti-EGFR CAR T-cells ==Preliminary data== ===Glioblastoma=== #'''INCIPIENT:''' Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Ni...")
- 18:00, 12 April 2024 Jwarner talk contribs created page Category:SPEAR T-cells (Created page with "Category:Immune effector cells")
- 18:00, 12 April 2024 Jwarner talk contribs created page Category:Anti-MAGE-A4 SPEAR T-cells (Created page with "Category:SPEAR T-cells")
- 17:59, 12 April 2024 Jwarner talk contribs created page Category:Liposarcoma medications (investigational) (Created page with "Category:Liposarcoma medications")
- 17:59, 12 April 2024 Jwarner talk contribs created page Afamitresgene Autoleucel (ADP-A2M4) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamitresgene-autoleucel NCI Drug Dictionary]: A preparation of autologous h...")
- 12:40, 10 April 2024 Jwarner talk contribs created page Hereditary hemorrhagic telangiectasia - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:25, 10 April 2024 Jwarner talk contribs created page Sickle cell anemia - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:21, 10 April 2024 Jwarner talk contribs created page Smoldering multiple myeloma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:34, 9 April 2024 Jwarner talk contribs created page Category:FDA withdrawn in 2024 (Created page with "Category:Discontinued drugs")
- 17:43, 30 March 2024 Jwarner talk contribs created page Category:Myeloid neoplasms (Created page with "Category:Malignant hematologic neoplasm")
- 13:24, 4 March 2024 Jwarner talk contribs created page Category:Pyruvate kinase deficiency regimens (Created page with "Category:Classical hematology regimens")
- 13:23, 4 March 2024 Jwarner talk contribs created page Category:Pyruvate kinase deficiency medications (Created page with "Category:Classical hematology medications")
- 13:22, 4 March 2024 Jwarner talk contribs created page Pyruvate kinase deficiency (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:32, 28 February 2024 Jwarner talk contribs created page Category:Medications by manufacturing method (Created page with "Category:Drugs")
- 14:32, 28 February 2024 Jwarner talk contribs created page Category:Recombinant medications (Created page with "Category:Medications by manufacturing method")
- 14:27, 28 February 2024 Jwarner talk contribs created page Category:Profibrinolytics (Created page with "Category:Classical hematology medications")
- 14:06, 28 February 2024 Jwarner talk contribs created page Category:Hemoglobin S polymerization inhibitors (Created page with "Category:Classical hematology medications")
- 13:08, 24 February 2024 Jwarner talk contribs created page Category:Antineoplastic bispecific antibodies (Created page with "Category:Targeted therapeutic Category:Bispecific antibody medications")
- 13:05, 24 February 2024 Jwarner talk contribs created page Category:Hematologic bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 13:04, 24 February 2024 Jwarner talk contribs created page Category:Immunostimulatory bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 12:35, 2 February 2024 Jwarner talk contribs moved page Momelotinib (CYT-387) to Momelotinib (Ojjaara) (FDA approval)
- 12:35, 2 February 2024 Jwarner talk contribs created page Category:EMA approved in 2024 (Created page with "Category:EMA approved drugs")
- 21:49, 23 January 2024 Jwarner talk contribs moved page Ovarian cancer, BRCA-mutated to Ovarian cancer, HRD-positive (Renaming to make the page more generic for HRD rather than just BRCA)
- 02:02, 20 January 2024 Jwarner talk contribs created page Category:Bcl-2 translation inhibitors (Created page with "Category:Apoptosis promoters")
- 02:02, 20 January 2024 Jwarner talk contribs created page Oblimersen (Genasense) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium NCI Drug Dictionary]: The sodium salt of a phosphorothioat...")
- 15:41, 19 January 2024 Jwarner talk contribs created page Category:Ornithine decarboxylase inhibitors (Created page with "Category:Enzyme inhibitors")
- 15:41, 19 January 2024 Jwarner talk contribs created page Eflornithine (Iwilfin) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride NCI Drug Dictionary]: A difluoromethylated ornith...")
- 01:26, 19 January 2024 Jwarner talk contribs created page Category:Complement pathway inhibitors (Created page with "Category:Hematology medications")
- 01:25, 19 January 2024 Jwarner talk contribs created page Category:Complement factor D inhibitors (Created page with "Category:Complement pathway inhibitors")
- 01:24, 19 January 2024 Jwarner talk contribs created page Danicopan (ALXN-2040) (Created page with "==Mechanism of action== Complement factor D inhibitor ==Preliminary data== ===Paroxysmal nocturnal hemoglobinuria (PNH)=== #'''ALPHA:'...")
- 18:06, 18 January 2024 Jwarner talk contribs created page Category:Anti-DLL3-CD3 bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 18:05, 18 January 2024 Jwarner talk contribs created page Tarlatamab (AMG-757) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against...")
- 12:18, 12 January 2024 Jwarner talk contribs created page Category:Cutaneous T-cell lymphoma medications (investigational) (Created page with "Category:Cutaneous T-cell lymphoma medications")
- 11:42, 6 January 2024 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease medications (Created page with "Category:Supportive medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia medications (Created page with "Category:Leukemia medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant medications (Created page with "Category:Acute lymphoblastic leukemia medications")
- 02:30, 2 January 2024 Jwarner talk contribs created page Category:FDA approved in 2024 (Created page with "Category:FDA approved drugs")
- 03:33, 30 December 2023 Jwarner talk contribs created page Hypereosinophilic syndrome - null regimens (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. These references provide further insight into the historical development o...")
- 13:59, 20 December 2023 Jwarner talk contribs created page Category:FAK inhibitors (Created page with "Category:Tyrosine kinase inhibitors")
- 13:58, 20 December 2023 Jwarner talk contribs created page Repotrectinib (Augtyro) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib NCI Drug Dictionary]: An orally available inhi...")
- 00:18, 17 December 2023 Jwarner talk contribs created page Glioblastoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 01:26, 2 December 2023 Jwarner talk contribs created page Autologous stem cells (Created page with "==General information== Class/mechanism: Hematopoietic stem/progenitor cells from the individual who is receiving the infusion <br>Route: IV <br>Extravasation: No information...")
- 23:46, 27 November 2023 Jwarner talk contribs moved page Nirogacestat (PF-03084014) to Nirogacestat (Ogsiveo) (FDA approval)
- 17:31, 26 November 2023 Jwarner talk contribs moved page Category:Local therapies to Category:Locally delivered therapies
- 15:13, 26 November 2023 Jwarner talk contribs created page Category:Cellular therapy regimens (Created page with "Category:Regimen index")
- 15:10, 26 November 2023 Jwarner talk contribs moved page Chimeric antigen receptor T cells (CAR-T) to Cellular therapy conditioning regimens
- 15:09, 26 November 2023 Jwarner talk contribs moved page Stem cell mobilization to Stem cell mobilization regimens
- 15:07, 26 November 2023 Jwarner talk contribs moved page Autologous HSCT to Autologous HSCT conditioning regimens over redirect
- 15:07, 26 November 2023 Jwarner talk contribs deleted redirect Autologous HSCT conditioning regimens by overwriting (Deleted to make way for move from "Autologous HSCT")
- 15:05, 26 November 2023 Jwarner talk contribs moved page Allogeneic HSCT to Allogeneic HSCT conditioning regimens over redirect
- 15:05, 26 November 2023 Jwarner talk contribs deleted redirect Allogeneic HSCT conditioning regimens by overwriting (Deleted to make way for move from "Allogeneic HSCT")
- 13:55, 26 November 2023 Jwarner talk contribs moved page Niraparib and Abiraterone (Akeega) to Niraparib and abiraterone (Akeega)
- 03:09, 26 November 2023 Jwarner talk contribs moved page Mycostatin (Nystatin) to Nystatin (Mycostatin) (error in brand naming)
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP2 inhibitors (Created page with "Category:PARP inhibitors")
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP1 inhibitors (Created page with "Category:PARP inhibitors")
- 18:05, 19 November 2023 Jwarner talk contribs created page Category:TYK2 inhibitors (Created page with "A member of the Janus kinase family of tyrosine kinases. Category:JAK inhibitors")
- 14:14, 18 November 2023 Jwarner talk contribs moved page Toripalimab (Loqtorz) to Toripalimab (Loqtorzi) (Brand name not spelled right)
- 15:10, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, third generation (Created page with "Category:Aromatase inhibitors")
- 15:09, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, second generation (Created page with "Category:Aromatase inhibitors")
- 15:08, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, first generation (Created page with "Category:Aromatase inhibitors")
- 15:03, 17 November 2023 Jwarner talk contribs created page Category:PMDA approved in 1995 (Created page with "Category:PMDA approved drugs")
- 14:26, 17 November 2023 Jwarner talk contribs moved page Anlotinib (AL-3818) to Anlotinib (Fukewei) (brand name)
- 12:32, 17 November 2023 Jwarner talk contribs moved page Capivasertib (AZD-5363) to Capivasertib (Truqap) (FDA approval)
- 11:50, 17 November 2023 Jwarner talk contribs created page Thyroid cancer, medullary - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:16, 15 November 2023 Jwarner talk contribs created page NCCN guidelines (Created page with "This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:44, 13 November 2023 Jwarner talk contribs created page Upper tract urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:12, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1977 (Created page with "Category:EMA approved drugs")
- 17:12, 7 November 2023 Jwarner talk contribs moved page Bacillus Calmette-Guérin (BCG) to BCG vaccine (INN)
- 01:28, 7 November 2023 Jwarner talk contribs created page CRC (Redirected page to Colorectal cancer) Tag: New redirect
- 01:00, 7 November 2023 Jwarner talk contribs created page Category:Warm autoimmune hemolytic anemia medications (Created page with "Category:Classical hematology medications")
- 00:59, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1955 (Created page with "Category:EMA approved drugs")
- 00:55, 7 November 2023 Jwarner talk contribs created page Category:Colorectal cancer medications (historic) (Created page with "Category:Colorectal cancer medications")
- 23:16, 6 November 2023 Jwarner talk contribs created page Category:Acquired hemophilia A medications (Created page with "Category:Acquired coagulopathy medications")
- 20:57, 6 November 2023 Jwarner talk contribs created page Mitomycin pyelocalyceal (Jelmyto) (Created page with "==Mechanism of action== Antibiotic oncologic isolated from Streptomyces caespitosus; inhibits DNA synthesis and induces crosslinking. Formulated for pyelocalyceal infusion. =...")
- 20:28, 6 November 2023 Jwarner talk contribs created page Lasofoxifene (Fablyn) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lasofoxifene NCI Drug Dictionary]: A non-steroidal, naphthalene-derived, thi...")
- 20:08, 6 November 2023 Jwarner talk contribs created page Fadrozole (Afema) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadrozole-hydrochloride NCI Data Dictionary]: The hydrochloride salt of the...")
- 19:33, 6 November 2023 Jwarner talk contribs created page Dinutuximab beta (Qarziba) (Created page with "==Mechanism of action== Anti-GD2 antibody ==Diseases for which it is used== *Neuroblastoma ==History of changes in EMA indication== *2017-05-08: Initial authorisation as...")
- 19:04, 6 November 2023 Jwarner talk contribs created page Chlorozotocin (DCNU) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin NCI Drug Dictionary]: A glucose-linked chloroethylnitrosourea...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-zerc (Zercepac) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Zercepac Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-herw (Herwenda) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Herwenda Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixi (Riximyo) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Riximyo Category:Drugs Category:Intravenous medications Category:Neutral Cate...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixa (Rixathon) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Rixathon Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rite (Ritemvia) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Ritemvia Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-blit (Blitzima) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Blitzima Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:57, 6 November 2023 Jwarner talk contribs created page Bevacizumab-onbe (Onbevzi) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Onbevzi Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-equi (Equidacent) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Equidacent Category:Drugs Category:Intravenous medications Category:Neutral [...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-aybi (Aybintio) (Created page with "'''Note: this is a bevacizumab biosimilar.'' ==Also known as== *'''Brand name:''' Aybintio Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 13:59, 6 November 2023 Jwarner talk contribs created page Anlotinib (AL-3818) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catequentinib-hydrochloride NCI Drug Dictionary]: The hydrochloride salt for...")
- 12:15, 6 November 2023 Jwarner talk contribs created page Cutaneous squamous cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 13:04, 5 November 2023 Jwarner talk contribs created page Systemic mastocytosis - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:54, 5 November 2023 Jwarner talk contribs created page Polycythemia vera - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:12, 5 November 2023 Jwarner talk contribs created page Meningioma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:07, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:00, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:36, 5 November 2023 Jwarner talk contribs created page JMML (Redirected page to Juvenile myelomonocytic leukemia) Tag: New redirect
- 00:14, 4 November 2023 Jwarner talk contribs moved page Fruquintinib (HMPL-013) to Fruquintinib (Elunate) (brand name)
- 20:52, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:49, 3 November 2023 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant regimens (Created page with "Category:Acute lymphoblastic leukemia regimens")
- 20:48, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:37, 1 November 2023 Jwarner talk contribs created page Merkel cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 10:59, 31 October 2023 Jwarner talk contribs created page Motixafortide (Aphexda) (Created page with "cyclic-peptide CXCR4 inhibitor Category:Drugs Category:CXCR4 inhibitor Category:FDA approved in 2023 Category:Stub")
- 23:34, 28 October 2023 Jwarner talk contribs created page Category:Anti-CLDN18.2 antibodies (Created page with "Category:Antineoplastic monoclonal antibodies")
- 23:33, 28 October 2023 Jwarner talk contribs created page Category:Gastric cancer medications (investigational) (Created page with "Category:Gastric cancer medications")
- 23:33, 28 October 2023 Jwarner talk contribs created page Zolbetuximab (IMAB-362) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolbetuximab NCI Drug Dictionary]: A chimeric immunoglobulin G1 (IgG1) monoc...")
- 21:53, 28 October 2023 Jwarner talk contribs created page Fitusiran (ALN-AT3SC) (Created page with "==Mechanism of action== siRNA therapeutic, targets antithrombin ==Preliminary data== ===Inherited coagulopathy=== #'''ATLAS-A/B:''' Srivastava A, Rangarajan S, Kavakli K,...")
- 21:34, 28 October 2023 Jwarner talk contribs created page Hepatic veno-occlusive disease - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 21:31, 28 October 2023 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease regimens (Created page with "Regimens with some demonstrated degree of efficacy in the treatment of hepatic veno-occlusive disease.")
- 21:30, 28 October 2023 Jwarner talk contribs created page Hepatic veno-occlusive disease (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:45, 26 October 2023 Jwarner talk contribs created page ASCO guidelines (Created page with "This page will be a gathering place for the American Society of Clinical Oncology (ASCO) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:51, 25 October 2023 Jwarner talk contribs created page Myelodysplastic syndrome, IDH-mutated (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:32, 24 October 2023 Jwarner talk contribs created page Category:KFDA approved in 2021 (Created page with "Category:KFDA approved drugs")
- 23:31, 24 October 2023 Jwarner talk contribs created page Lazertinib (Leclaza) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib NCI Drug Dictionary]: An orally available third-g...")
- 22:44, 15 October 2023 Jwarner talk contribs created page ESMO guidelines (Created page with "This page will be a gathering place for ESMO guidelines that do not clearly fit under a disease-specific page. =Fertility & Pregnancy= *'''2013:''' Peccatori et al. [https://...")
- 20:38, 14 October 2023 Jwarner talk contribs created page Tenosynovial giant cell tumor - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:34, 14 October 2023 Jwarner talk contribs created page Subependymal giant cell astrocytoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:08, 14 October 2023 Jwarner talk contribs created page Myelodysplastic syndrome - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:42, 11 October 2023 Jwarner talk contribs created page PJP Prophylaxis (Created page with "The purpose of this page is to list the various types of PJP prophylaxis in common usage. ==Guidelines== ==Prophylaxis== ===Trimethoprim-Sulfamethoxazole (Bactrim DS)|Tri...")
- 20:55, 3 October 2023 Jwarner talk contribs created page Category:Anti-Factor IXa/Factor Xa bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 20:55, 3 October 2023 Jwarner talk contribs created page Category:Anti-EGFR/HGFR bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 20:50, 3 October 2023 Jwarner talk contribs moved page Category:Anti-GPRC5D bispecific T-cell engager antibodies to Category:Anti-GPRC5D/CD3 bispecific antibodies
- 20:47, 3 October 2023 Jwarner talk contribs moved page Category:Anti-EpCAM bispecific T-cell engager antibodies to Category:Anti-EpCAM/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD33 bispecific T-cell engager antibodies to Category:Anti-CD33/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD19 bispecific T-cell engager antibodies to Category:Anti-CD19/CD3 bispecific antibodies
- 20:43, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD20 bispecific T-cell engager antibodies to Category:Anti-CD20/CD3 bispecific antibodies
- 20:40, 3 October 2023 Jwarner talk contribs moved page Category:Anti-BCMA bispecific T-cell engager antibodies to Category:Anti-BCMA/CD3 bispecific antibodies
- 19:56, 3 October 2023 Jwarner talk contribs created page Category:Small bowel adenocarcinoma medications (Created page with "Category:Gastrointestinal oncology medications")
- 22:20, 1 October 2023 Jwarner talk contribs created page Category:PMDA approved in 1981 (Created page with "Category:PMDA approved drugs")
- 22:15, 1 October 2023 Jwarner talk contribs created page Category:Loop diuretics (Created page with "Category:Diuretics")
- 21:45, 1 October 2023 Jwarner talk contribs created page Category:Light-chain (AL) amyloidosis medications (investigational) (Created page with "Category:Light-chain (AL) amyloidosis medications")
- 15:22, 29 September 2023 Jwarner talk contribs moved page Folinic acid (Leucovorin) to Leucovorin (Folinic acid) (Alignment with INN)
- 20:13, 26 September 2023 Jwarner talk contribs created page Germ cell tumor (Created page with "At this point we do not have a dedicated page for germ cell tumors. More information about this broad class of tumors can be found [https://en.wikipedia.org/wiki/Germ_cell_tum...")
- 15:22, 23 September 2023 Jwarner talk contribs created page Category:Malignant neoplasm (Created page with "Category:Condition")
- 14:30, 23 September 2023 Jwarner talk contribs created page Category:TGF-beta inhibitors (Created page with "Category:Erythrocyte growth factors")
- 14:24, 23 September 2023 Jwarner talk contribs created page Category:Urate oxidase (Created page with "Category:Uric acid lowering agents")
- 12:16, 23 September 2023 Jwarner talk contribs created page Category:Synthetic muramyl dipeptides (Created page with "Category:Immunotherapeutic")
- 11:51, 23 September 2023 Jwarner talk contribs created page Category:GnRH analogs (Created page with "Category:Endocrine therapeutic")
- 11:27, 23 September 2023 Jwarner talk contribs created page Category:JAK3 inhibitors (Created page with "Category:JAK inhibitors")
- 11:25, 23 September 2023 Jwarner talk contribs created page Category:JAK1 inhibitors (Created page with "Category:JAK inhibitors")
- 11:24, 23 September 2023 Jwarner talk contribs created page Category:JAK2 inhibitors (Created page with "Category:JAK inhibitors")
- 00:29, 23 September 2023 Jwarner talk contribs created page Category:Anti-IL-2R immunotoxins (Created page with "Category:Immunotoxin")
- 00:12, 23 September 2023 Jwarner talk contribs created page Category:Topoisomerase II inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 23:38, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) medications to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) medications
- 23:37, 22 September 2023 Jwarner talk contribs moved page SMO or PTCH-1 (Hedgehog) to Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog)
- 23:37, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) regimens to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) regimens
- 23:33, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H medications to Category:Malignant solid neoplasm, TMB-H medications
- 23:32, 22 September 2023 Jwarner talk contribs moved page TMB-H to Malignant solid neoplasm, TMB-H
- 23:32, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H regimens to Category:Malignant solid neoplasm, TMB-H regimens
- 23:31, 22 September 2023 Jwarner talk contribs moved page Category:RET medications to Category:Malignant solid neoplasm, RET-mutated medications
- 23:30, 22 September 2023 Jwarner talk contribs moved page RET to Malignant solid neoplasm, RET-mutated
- 23:29, 22 September 2023 Jwarner talk contribs moved page Category:RET regimens to Category:Malignant solid neoplasm, RET-mutated regimens
- 23:37, 21 September 2023 Jwarner talk contribs created page Category:Malignant solid neoplasm, NTRK-mutated medications (Created page with "Medications with some degree of efficacy in the treatment of NTRK-mutated solid tumors, regardless of anatomic site of origin. Ca...")
- 23:33, 21 September 2023 Jwarner talk contribs moved page Category:NTRK regimens to Category:Malignant solid neoplasm, NTRK-mutated regimens
- 23:32, 21 September 2023 Jwarner talk contribs moved page NTRK to Malignant solid neoplasm, NTRK-mutated
- 23:24, 21 September 2023 Jwarner talk contribs moved page Category:MSI-H or dMMR medications to Category:Malignant solid neoplasm, MSI-H or dMMR medications
- 23:23, 21 September 2023 Jwarner talk contribs moved page Category:MSI-H or dMMR regimens to Category:Malignant solid neoplasm, MSI-H or dMMR regimens
- 23:22, 21 September 2023 Jwarner talk contribs moved page MSI-H or dMMR to Malignant solid neoplasm, MSI-H or dMMR
- 21:48, 21 September 2023 Jwarner talk contribs moved page ERBB3 (HER3) to Malignant solid neoplasm, ERBB3-mutated
- 21:48, 21 September 2023 Jwarner talk contribs moved page Category:ERBB3 (HER3) regimens to Category:Malignant solid neoplasm, ERBB3-mutated regimens
- 21:07, 21 September 2023 Jwarner talk contribs moved page Category:ERBB3 (HER3) medications to Category:Malignant solid neoplasm, ERBB3-mutated medications
- 21:07, 21 September 2023 Jwarner talk contribs moved page Category:ERBB2 (HER2) medications to Category:Malignant solid neoplasm, ERBB2-mutated medications
- 21:05, 21 September 2023 Jwarner talk contribs moved page Category:ERBB2 (HER2) regimens to Category:Malignant solid neoplasm, ERBB2-mutated regimens
- 21:04, 21 September 2023 Jwarner talk contribs moved page ERBB2 (HER2) to Malignant solid neoplasm, ERBB2-mutated
- 16:27, 21 September 2023 Jwarner talk contribs moved page Category:Solid malignant neoplasm, EGFR-mutated regimens to Category:Malignant solid neoplasm, EGFR-mutated regimens
- 16:27, 21 September 2023 Jwarner talk contribs moved page Solid malignant neoplasm, EGFR-mutated to Malignant solid neoplasm, EGFR-mutated
- 16:26, 21 September 2023 Jwarner talk contribs moved page Category:Solid malignant neoplasm, EGFR-mutated medications to Category:Malignant solid neoplasm, EGFR-mutated medications
- 16:07, 21 September 2023 Jwarner talk contribs moved page Category:EGFR medications to Category:Solid malignant neoplasm, EGFR-mutated medications
- 16:04, 21 September 2023 Jwarner talk contribs moved page Category:EGFR regimens to Category:Solid malignant neoplasm, EGFR-mutated regimens
- 16:03, 21 September 2023 Jwarner talk contribs moved page EGFR to Solid malignant neoplasm, EGFR-mutated
- 15:15, 21 September 2023 Jwarner talk contribs moved page Category:BRAF medications to Category:Malignant solid neoplasm, BRAF-mutated medications
- 15:13, 21 September 2023 Jwarner talk contribs moved page Category:BRAF regimens to Category:Malignant solid neoplasm, BRAF-mutated regimens
- 15:12, 21 September 2023 Jwarner talk contribs moved page BRAF to Malignant solid neoplasm, BRAF-mutated
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Anti-dabigatran antibody fragments (Created page with "Category:Anticoagulant reversal agents")
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Anticoagulant reversal agents (Created page with "Category:Classical hematology medications")
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Heparin antagonist (Created page with "Category:Anticoagulant reversal agents")
- 23:30, 18 September 2023 Jwarner talk contribs created page Category:Small bowel carcinoma medications (Created page with "Category:Gastrointestinal oncology medications")
- 23:28, 18 September 2023 Jwarner talk contribs created page Category:Folic acid analog (Created page with "Category:Potentiating agents Category:Chemotherapy protective agents")
- 23:27, 18 September 2023 Jwarner talk contribs created page Category:Potentiating agents (Created page with "A category of drugs that potentiate the effect of another drug or localized intervention. Category:Drugs")
- 15:20, 15 September 2023 Jwarner talk contribs created page Category:Anti-CD7 CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:20, 15 September 2023 Jwarner talk contribs created page Category:T-cell acute lymphoblastic leukemia medications (investigational) (Created page with "Category:T-cell acute lymphoblastic leukemia medications")
- 15:19, 15 September 2023 Jwarner talk contribs created page BE-CAR7 (Created page with "==Mechanism of action== Base-edited ("off the shelf") CAR T-cells directed against CD7 ==Preliminary data== #Chiesa R, Georgiadis C, Syed F, Zhan H, Etuk A, Gkazi SA, Preece...")
- 14:55, 15 September 2023 Jwarner talk contribs created page Category:Cereblon E3 ubiquitin ligase modulators (Created page with "Category:Enzyme inhibitors")
- 14:54, 15 September 2023 Jwarner talk contribs created page Mezigdomide (BMS-986348) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mezigdomide NCI Drug Dictionary]: A modulator of the E3 ubiquitin ligase com...")
- 16:44, 13 September 2023 Jwarner talk contribs created page Category:Topoisomerase I inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 16:41, 13 September 2023 Jwarner talk contribs created page Category:Alkyl sulfonates (Created page with "Category:Alkylating agents")
- 19:23, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma medications (investigational) (Created page with "Category:Urothelial carcinoma medications")
- 13:44, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinomas (Created page with "Category:Genitourinary cancers")
- 12:35, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma medications (Created page with "Medications which have been shown to have some degree of efficacy in the treatment of urothelial carcinoma. Category:Genitourinary oncology medications")
- 12:21, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma regimens (Created page with "Category:Genitourinary (GU) oncology regimens")
- 12:16, 9 September 2023 Jwarner talk contribs created page Urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:04, 9 September 2023 Jwarner talk contribs moved page Bladder cancer - historical to Urothelial carcinoma - historical
- 11:53, 9 September 2023 Jwarner talk contribs moved page Bladder cancer to Urothelial carcinoma
- 16:31, 7 September 2023 Jwarner talk contribs moved page Olverembatinib (HQP1351) to Olverembatinib (HQP-1351) (naming standardization)
- 01:25, 7 September 2023 Jwarner talk contribs created page How I Treat (Created page with "The "How I Treat" series has been published by ''Blood'' for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles ar...")
- 20:59, 5 September 2023 Jwarner talk contribs created page Category:Small bowel carcinoma regimens (Created page with "Category:Gastrointestinal (GI) oncology regimens")
- 20:58, 5 September 2023 Jwarner talk contribs created page Small bowel adenocarcinoma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:09, 4 September 2023 Jwarner talk contribs moved page Eculizumab (Epysqli) to Eculizumab-epys (Epysqli) (Biosimilar naming convention)
- 12:08, 4 September 2023 Jwarner talk contribs moved page Eculizumab (Bekemv) to Eculizumab-beke (Bekemv) (Biosimilar naming convention)
- 12:02, 4 September 2023 Jwarner talk contribs created page Eculizumab (Bekemv) (Created page with "==General information== Class/mechanism: Complement inhibitor; monoclonal antibody that binds to complement protein C5, preventing its cleavage to C5a and C5b and the formatio...")
- 12:02, 4 September 2023 Jwarner talk contribs created page Eculizumab (Epysqli) (Created page with "==General information== Class/mechanism: Complement inhibitor; monoclonal antibody that binds to complement protein C5, preventing its cleavage to C5a and C5b and the formatio...")
- 20:11, 3 September 2023 Jwarner talk contribs created page Category:Anti-TFPI antibodies (Created page with "Category:Hematologic monoclonal antibodies")
- 20:11, 3 September 2023 Jwarner talk contribs created page Concizumab (Alhemo) (Created page with "Anti-TFPI antibody ==Supporting data== *'''explorer7:''' Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J,...")
- 11:15, 30 August 2023 Jwarner talk contribs created page Category:ACVR1 inhibitors (Created page with "A class of drugs that inhibit activin A receptor, type I (ACVR1). Category:Serine/threonine kinase inhibitors")
- 10:45, 30 August 2023 Jwarner talk contribs created page Category:Myelodysplastic syndrome medications (investigational) (Created page with "Category:Myelodysplastic syndrome medications")
- 23:31, 29 August 2023 Jwarner talk contribs created page Breast cancer, triple negative - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 18:47, 29 August 2023 Jwarner talk contribs created page Breast cancer, ER-positive - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:19, 27 August 2023 Jwarner talk contribs created page Breast cancer, ER-positive - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 01:01, 27 August 2023 Jwarner talk contribs created page Breast cancer, HER2-positive - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:29, 24 August 2023 Jwarner talk contribs created page Divarasib (GDC-6036) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divarasib NCI Drug Dictionary]: An orally available inhibitor of the oncogen...")
- 23:19, 17 August 2023 Jwarner talk contribs created page Category:Statins (Created blank page)
- 23:19, 17 August 2023 Jwarner talk contribs created page Simvastatin (Zocor) (Created page with "A statin with possible antileukemic properties. ==Also known as== *'''Brand name:''' Zocor Category:Drugs Category:Oral medications Category:Statins Category:F...")
- 21:05, 17 August 2023 Jwarner talk contribs created page MZL (Redirected page to Marginal zone lymphoma) Tag: New redirect
- 21:03, 16 August 2023 Jwarner talk contribs created page Melphalan for Injection/Hepatic Delivery System (Hepzato Kit) (Created page with "==General information== Class/mechanism: Nitrogen mustard, alkylator ==Diseases for which it is established== *Uveal melanoma ==History of changes in FDA indication== *2...")
- 11:19, 16 August 2023 Jwarner talk contribs created page Olverembatinib (HQP1351) (Created page with "==Mechanism of action== Third-generation TKI ==Diseases for which it is used== *Chronic myeloid leukemia ==History of changes in NMPA indication== *2021-11: Initial cond...")
- 12:22, 15 August 2023 Jwarner talk contribs created page Large language model pilot (Created page with "We are conducting a pilot of generative artificial intelligence to create human-readable synopses for some of the most relevant anticancer regimens on HemOnc.org. The goal of...")
- 18:52, 14 August 2023 Jwarner talk contribs created page Elranatamab (Elrexfio) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elranatamab NCI Drug Dictionary]: A bispecific monoclonal an...")
- 12:47, 12 August 2023 Jwarner talk contribs created page Niraparib and Abiraterone (Akeega) (Created page with "==Mechanism of action== A fixed dose combination of niraparib and abiraterone. Niraparib inhibits poly(ADP-ribose) polymerase (PARP) enzymes PARP-1 and PARP-2, which are invol...")
- 02:23, 11 August 2023 Jwarner talk contribs moved page Tislelizumab (BGB-A317) to Tislelizumab (Baizean) (brand name)
- 02:13, 11 August 2023 Jwarner talk contribs moved page Zimberelimab (AB-122) to Zimberelimab (Yu Duo) (brand name)
- 14:42, 10 August 2023 Jwarner talk contribs moved page Talquetamab (JNJ-64407564) to Talquetamab (Talvey) (FDA approval)
- 14:00, 3 August 2023 Jwarner talk contribs created page Donafenib (Zepsun) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donafenib NCI Drug Dictionary]: An orally available multikinase inhibitor th...")
- 18:18, 2 August 2023 Jwarner talk contribs created page Category:Aggressive non-Hodgkin lymphomas (Created page with "Category:Aggressive lymphomas")
- 14:12, 1 August 2023 Jwarner talk contribs created page Category:Interferon gammas (Created page with "Category:Interferons")
- 14:10, 1 August 2023 Jwarner talk contribs created page Category:Interferon alfas (Created page with "Category:Interferons")
- 01:52, 26 July 2023 Jwarner talk contribs created page Category:NMPA approved in 2009 (Created page with "Category:NMPA approved drugs")
- 01:52, 26 July 2023 Jwarner talk contribs created page Realgar-Indigo naturalis formulation (Created page with "==Mechanism of action== From [https://en.wikipedia.org/wiki/Realgar/Indigo_naturalis Wikipedia]: The basic action of this medication is similar to arsenic trioxide in that the...")
- 01:48, 26 July 2023 Jwarner talk contribs created page Histamine dihydrochloride (Ceplene) (Created page with "==Mechanism of action== From [https://en.wikipedia.org/wiki/Histamine_dihydrochloride Wikipedia]: Histamine dihydrochloride acts by improving the immune-enhancing properties o...")
- 00:39, 26 July 2023 Jwarner talk contribs created page Trofosfamide (Ixoten) (Created page with "''Note: this drug appears to only be approved in Germany.'' Nitrogen mustard, alkylating agent Category:Drugs Category:Oral medications [[Category:Alkylating agents]...")
- 00:34, 26 July 2023 Jwarner talk contribs created page Temoporfin (Foscan) (Created page with "==Mechanism of action== Photosensitizer ==Diseases for which it is used== *Head and neck cancer Category:Drugs Category:Intravenous medications Category:Photos...")
- 00:32, 26 July 2023 Jwarner talk contribs created page Category:Anti-NGcGM3 antibodies (Created page with "Category:Immunostimulatory monoclonal antibodies")
- 00:31, 26 July 2023 Jwarner talk contribs created page Racotumomab (Vaxira) (Created page with "''This drug is currently approved in Argentina and Cuba.'' ==Mechanism of action== From [https://en.wikipedia.org/wiki/Racotumomab Wikipedia]: Racotumomab is an anti-idiotypic...")
- 00:23, 26 July 2023 Jwarner talk contribs created page Padeliporfin (Tookad) (Created page with "==Mechanism of action== Photosensitizer ==Diseases for which it is used== *Prostate cancer Category:Drugs Category:Photosensitizers Category:Prostate cancer me...")
- 00:20, 26 July 2023 Jwarner talk contribs created page Mifamurtide (Mepact) (Created page with "==Mechanism of action== Fully synthetic derivative of muramyl dipeptide (MDP) ==Diseases for which it is used== *Osteosarcoma ==History of changes in EMA indication== *2...")
- 17:12, 25 July 2023 Jwarner talk contribs created page Category:Craniopharyngioma medications (Created page with "Category:Neurooncology medications")
- 17:10, 25 July 2023 Jwarner talk contribs created page Category:Craniopharyngioma regimens (Created page with "Category:Neurooncology regimens")
- 17:10, 25 July 2023 Jwarner talk contribs created page Craniopharyngioma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:05, 24 July 2023 Jwarner talk contribs created page Category:Low-grade glioma medications (investigational) (Created page with "Category:Low-grade glioma medications")
- 14:05, 24 July 2023 Jwarner talk contribs created page Vorasidenib (AG-881) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorasidenib NCI Drug Dictionary]: An orally available inhibitor of mutated f...")
- 06:03, 23 July 2023 Jwarner talk contribs created page ASPS (Redirected page to Alveolar soft part sarcoma) Tag: New redirect
- 06:00, 23 July 2023 Jwarner talk contribs created page Category:Alveolar soft part sarcoma regimens (Created page with "Category:Soft tissue sarcoma regimens")
- 06:00, 23 July 2023 Jwarner talk contribs created page Alveolar soft part sarcoma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 05:44, 23 July 2023 Jwarner talk contribs created page Category:Inflammatory myofibroblastic tumor medications (Created page with "Category:Soft tissue sarcoma medications")
- 05:42, 23 July 2023 Jwarner talk contribs created page Category:Inflammatory myofibroblastic tumor regimens (Created page with "Category:Soft tissue sarcoma regimens")
- 05:41, 23 July 2023 Jwarner talk contribs created page Inflammatory myofibroblastic tumor (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:02, 23 July 2023 Jwarner talk contribs created page Sitagliptin (Januvia) (Created page with "Category:Drugs Category:Stub")
- 04:57, 9 July 2023 Jwarner talk contribs created page Category:Photosensitizers (Created page with "A class of drugs that act as potentiating agents when exposed to certain wavelengths of light.")
- 12:26, 4 July 2023 Jwarner talk contribs moved page Category:Anti-IL3 immunotoxins to Category:IL-3 fused immunotoxins